GENEVA, Aug. 11 -- AC IMMUNE SA (EPFL Innovation Park, Building B1015 Lausanne) filed a patent application (PCT/EP2025/052396) for "NOVEL COMPOUNDS" on Jan 30, 2025. With publication no. WO/2025/163069, the details related to the patent application was published on Aug 07, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MOLETTE, Jerome (EPFL Innovation Park, Building B1015 Lausanne)
Abstract:
The present invention relates to novel compounds for the treatment, alleviation or prevention of a group of diseases, disorders and abnormalities which are responsive to the modulation or inhibition ...